RENB
Price:
$1.42
Market Cap:
$17.14M
Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms. These advanced technologies are aimed at providing treatments for a range of infectious diseases and oncological conditions. The company's development pipeline features several candidates, specifically ENOB-HV-01, ENOB-HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. Founded on January 18, 2011, by Rene Sindlev and Serhat Gumrukcu, Lunai Bioworks maintains its corporate base in Los Angeles, California.
Industry
Biotechnology
IPO Date
2018-02-07
Stock Exchange
NASDAQ
Ticker
RENB
According to Lunai Bioworks Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.13. This represents a change of -57.55% compared to the average of -0.31 of the last 4 quarters.
The mean historical PE Ratio of Lunai Bioworks Inc. over the last ten years is -0.26. The current -0.13 PE Ratio has changed 4.99% with respect to the historical average. Over the past ten years (40 quarters), RENB's PE Ratio was at its highest in in the March 2025 quarter at 48.72. The PE Ratio was at its lowest in in the December 2025 quarter at -2.88.
Average
-0.26
Median
-0.25
Minimum
-0.40
Maximum
-0.11
Discovering the peaks and valleys of Lunai Bioworks Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.23%
Maximum Annual PE Ratio = -0.11
Minimum Annual Increase = -73.75%
Minimum Annual PE Ratio = -0.40
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.21 | -15.58% |
| 2024 | -0.25 | -21.98% |
| 2023 | -0.32 | 204.23% |
| 2022 | -0.11 | -73.75% |
The current PE Ratio of Lunai Bioworks Inc. (RENB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.26
5-year avg
-0.26
10-year avg
-0.26
Lunai Bioworks Inc.’s PE Ratio is greater than Angion Biomedica Corp. (-0.42), greater than Marinus Pharmaceuticals, Inc. (-0.21), less than LianBio (2.47), greater than Opus Genetics, Inc. (-3.11), greater than Grace Therapeutics, Inc. (-3.74), greater than Allakos Inc. (-1.15), greater than Serina Therapeutics, Inc. (-1.07), greater than Oruka Therapeutics, Inc. (-30.27), greater than Satsuma Pharmaceuticals, Inc. (-0.51), greater than Freeline Therapeutics Holdings plc (-0.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.42 | $30.11M | |
| -0.21 | $30.37M | |
| 2.47 | $12.11M | |
| -3.11 | $336.04M | |
| -3.74 | $36.83M | |
| -1.15 | $29.74M | |
| -1.07 | $22.75M | |
| -30.27 | $2.71B | |
| -0.51 | $36.47M | |
| -0.29 | $28.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lunai Bioworks Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lunai Bioworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lunai Bioworks Inc.'s PE Ratio?
How is the PE Ratio calculated for Lunai Bioworks Inc. (RENB)?
What is the highest PE Ratio for Lunai Bioworks Inc. (RENB)?
What is the 3-year average PE Ratio for Lunai Bioworks Inc. (RENB)?
What is the 5-year average PE Ratio for Lunai Bioworks Inc. (RENB)?
How does the current PE Ratio for Lunai Bioworks Inc. (RENB) compare to its historical average?